Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

医学 银屑病性关节炎 类风湿性关节炎 强直性脊柱炎 贾纳斯激酶 银屑病 抗风湿药 持久性(不连续性) 关节炎 肿瘤坏死因子α 内科学 皮肤病科 肿瘤科 免疫学 受体 岩土工程 工程类
作者
Blanca Hernández‐Cruz,Lucia Otero Varela,Mercedes Freire-González,Noemí Busquets-Pérez,A González,Manuel José Moreno Ramos,J. M. Blanco-Madrigal,Sara Manrique‐Arija,Eva Pérez‐Pampín,D. Ruiz-Montesinos,Fernando Sánchez‐Alonso,Carlos Sánchez‐Piedra,Isabel Castrejón
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:: ard-225271 被引量:3
标识
DOI:10.1136/ard-2023-225271
摘要

Objectives To compare the safety of Janus kinase inhibitors (JAKi) with that of tumour necrosis factor inhibitors (TNFi) and determine drug persistence among patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). Methods We analysed data from patients included in BIOBADASER 3.0 and treated with JAKi or TNFi from 2015 to 2023 and estimated the incidence rate ratio (IRR) of adverse events and persistence. Results A total of 6826 patients were included. Of these, 52% had RA, 25% psoriatic arthritis and 23% axial SpA. Treatment was with TNFi in 86%. The mean duration of treatment was 2.2±2.0 years with TNFi versus 1.8±1.5 with JAKi. JAKis were prescribed in older patients with longer term disease, greater comorbidity and later treatment lines and more frequently as monotherapy. The IRR of all infections and gastrointestinal events was higher among patients with RA treated with JAKi. Drug persistence at 1, 2 and 3 years was 69%, 55% and 45% for TNFi and 68%, 54% and 45% for JAKi. Multivariate regression models showed a lower probability of discontinuation for JAKi (HR=0.85; 95% CI 0.78–0.92) and concomitant conventional synthetic disease-modifying antirheumatic drugs (HR=0.90; 95% CI 0.84–0.96). The risk of discontinuation increased with glucocorticoids, comorbidities, greater disease activity and later treatment lines. Conclusions Infections, herpes zoster and gastrointestinal adverse events in patients with RA tended to be more frequent with JAKi. However, prognosis was poor in patients receiving JAKi. Persistence was similar for TNFi and JAKi, although factors associated with discontinuation differed by diagnostic group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助风中的非笑采纳,获得10
刚刚
1秒前
1秒前
1秒前
微纳组刘同完成签到,获得积分10
1秒前
2秒前
2秒前
3秒前
123完成签到,获得积分10
3秒前
完美梨愁发布了新的文献求助10
4秒前
淡淡博完成签到 ,获得积分10
4秒前
wjxcl发布了新的文献求助10
4秒前
6秒前
sdl发布了新的文献求助10
6秒前
emmm完成签到 ,获得积分10
7秒前
十三发布了新的文献求助10
7秒前
8秒前
8秒前
liangmh完成签到,获得积分10
8秒前
一二不休完成签到,获得积分10
8秒前
123发布了新的文献求助10
9秒前
11秒前
ding应助黑熊安巴尼采纳,获得10
12秒前
Ava应助wjxcl采纳,获得10
12秒前
闪闪如南发布了新的文献求助10
12秒前
深情安青应助一二不休采纳,获得10
13秒前
15秒前
123完成签到,获得积分10
15秒前
不扯先生完成签到,获得积分10
16秒前
柳絮完成签到,获得积分20
17秒前
lll完成签到,获得积分10
17秒前
sdl完成签到,获得积分10
17秒前
Orange应助孟婆的碗采纳,获得10
18秒前
zhangmy1989发布了新的文献求助30
18秒前
18秒前
清秀的不言完成签到 ,获得积分10
18秒前
杂化轨道退役研究员完成签到,获得积分10
18秒前
FashionBoy应助tanglu采纳,获得10
19秒前
20秒前
闪闪如南完成签到,获得积分10
21秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048